Zhenbao Technology announced that from January to June 2026, it achieved operating income of 484 million yuan, an increase of 31.98%; net profit attributable to shareholders of listed companies was 107 million yuan, an increase of 25.74% year on year; after deducting non-net profit of 102 million yuan, an increase of 19.06% year on year. R&D investment was 43.7303 million yuan, up 65.05% year on year. R&D investment accounted for 9.04% of revenue, up 1.81 percentage points year on year. At the end of June 2026, the company's net assets were 2,926 billion yuan, with total assets of 3.344 billion yuan, up 141.80% and 106.59% respectively from the end of the previous year. The main reason was that the company completed the Science and Technology Innovation Board IPO fund-raising in June 2026. During the continuous supervision period, no major problems or major irregularities were discovered in the company, no major adverse changes in core competitiveness, compliance with the use of capital raised, and no changes in shareholding, pledge freezing or reduction of holdings by controlling shareholders, directors and supervisors.

Zhenbao Technology announced that from January to June 2026, it achieved operating income of 484 million yuan, an increase of 31.98%; net profit attributable to shareholders of listed companies was 107 million yuan, an increase of 25.74% year on year; after deducting non-net profit of 102 million yuan, an increase of 19.06% year on year. R&D investment was 43.7303 million yuan, up 65.05% year on year. R&D investment accounted for 9.04% of revenue, up 1.81 percentage points year on year. At the end of June 2026, the company's net assets were 2,926 billion yuan, with total assets of 3.344 billion yuan, up 141.80% and 106.59% respectively from the end of the previous year. The main reason was that the company completed the Science and Technology Innovation Board IPO fund-raising in June 2026. During the continuous supervision period, no major problems or major irregularities were discovered in the company, no major adverse changes in core competitiveness, compliance with the use of capital raised, and no changes in shareholding, pledge freezing or reduction of holdings by controlling shareholders, directors and supervisors.